$2,175.35 general Payment -- Amgen Inc to Dr. James Wilson
Nephrologist James Wilson Receives $2,175.35 from Amgen for Services Related to Farxiga
This page provides a detailed analysis of a $2,175.35 general payment from Amgen Inc to Dr. James Wilson. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $2,175.35 |
| Payment Type | general |
| Payment Nature | Compensation for services other than consulting |
| Pharmaceutical Company | Amgen Inc |
| Physician | Dr. James Wilson |
| NPI Number | 1770689437 |
| Physician Specialty | Nephrology |
| Location | Miami, FL |
| Date of Payment | 2025-04-16 |
| Related Drug/Device | Farxiga |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Amgen Inc made a $2.2K general payment to James Wilson, a Nephrology specialist in Miami, FL. The payment was associated with Farxiga. The payment of $2,175.35 to Dr. James Wilson by Amgen Inc. is for services other than consulting. This payment is associated with the drug Farxiga, a treatment relevant to Nephrology. The payment was made on April 16, 2025, and recorded under payment ID OP-MNJ1DDWP-VIA1IS.
Patient Guidance: What This Payment Means for You
If you are prescribed Farxiga by your doctor, this payment information may help you understand the relationship between your physician and the drug manufacturer. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
For nephrologists, payments for services other than consulting can include speaker fees, advisory board participation, or compensation for research, with amounts varying widely based on the service provided.
Regulatory Context: Sunshine Act Requirements
This payment is subject to reporting requirements under the Physician Payments Sunshine Act, part of the Affordable Care Act, which aims to increase transparency in financial relationships between the healthcare industry and physicians.
Related Topics
This payment is related to the following healthcare transparency topics:
- cms-open-payments
- pharma-payments
- nephrology
- amgen
- farxiga
- physician-compensation
Understanding general Payments
general payments are one of several categories of financial transfers from pharmaceutical and medical device companies to physicians that must be reported under the Sunshine Act. Understanding the type and context of a payment is important for evaluating its significance. Not all payments are equal -- a research grant has very different implications than a promotional speaking fee.
Frequently Asked Questions About This Payment
What was this $2.2K payment for?
This was a general payment of $2.2K from Amgen Inc to James Wilson, categorized as "Compensation for services other than consulting". It was associated with Farxiga. The payment was reported under the Sunshine Act (CMS Open Payments).
Does James Wilson accept pharmaceutical money?
Yes, James Wilson received this $2.2K payment from Amgen Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view James Wilson's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this general payment?
A general payment of $2.2K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Nephrology?
To compare this payment against Nephrology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Nephrology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about James Wilson's relationship with Amgen Inc?
The payment amount is relatively modest, suggesting it's not a large consulting fee. This $2.2K general payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Nephrology?
The payment nature specifies 'Compensation for services other than consulting,' indicating a specific service was rendered.
What should patients do after learning about this payment?
If you are prescribed Farxiga by your doctor, this payment information may help you understand the relationship between your physician and the drug manufacturer.
What else should I know about this general payment?
The drug Farxiga is commonly prescribed for conditions treated by nephrologists, such as chronic kidney disease and type 2 diabetes.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.